Meet Danni Cerezo! She's the events manager at 1Day Sooner and is responsible for the planning and logistics behind many of the events you see promoted on this platform!
1Day Sooner
@1daysooner
Advocating for challenge trial volunteers, who get diseases to help test new vaccines and enable other critical medical advances.
945 Following 1.8K Followers 4.2K Posts
Latest posts 5
Trials We Love!
What’s happening? In a Phase 1 trial, 212 healthy adults aged 18 to 80 received two doses of ARCT-2304, a self-amplifying mRNA vaccine against H5N1 bird flu.
What’s happening? In a Phase 1 trial, 212 healthy adults aged 18 to 80 received two doses of ARCT-2304, a self-amplifying mRNA vaccine against H5N1 bird flu.
Reminder: This event is happening tomorrow and you can still register here: us02web.zoom.us/webinar/regist…
us02web.zoom.us Video Conferencing, Web Conferencing, Webinars, Screen Sharing Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom... Can data from health records and insurance claims make medical research faster, cheaper, and more informative?
Join us Monday, Nov 9 at 10:30 AM ET for a live expert panel on real-world evidence in clinical research and regulatory decision-making.View quoted post on X
Clinical trials in the US are slow, costly, and often out of reach for patients who might benefit from participation. 1Day Sooner and 18 organizations, 13 of them rare disease groups, are backing the bipartisan Faster Clinical Trials Act from @RepAuchincloss and @RepMGriffith.
Infinita is proudly declaring its support for the "Faster Clinical Trials Act", a bipartisan bill introduced by Reps.
@JakeAuch (D-MA) and @RepMGriffith (R-VA).
Clinical trial reform at the federal level has suffered from a lack of ambition.
This is the first bill that I've seen that is not lacking ambition whatsoever.
"The bill also sets targets to reduce the cost per patient for the clinical trials conducted by these networks by 30 to 50 percent and speed participant enrollment in those trials by 30 percent."
The mechanisms how to reduce costs are a distillation best policy research that I've seen over the years, incl. by @IFP, @RuxandraTeslo, @sytses & many more
The things I am most excited about:
- Bringing evidence generation closer into the clinic; proving real-world effectiveness has been an afterthought in FDA approvals, leading to lack of safety & efficacy
- Streamlined trial site networks that can be accessed via a "multi-site, single-IRB", overcoming the IRB fragmentation that is a major source of delay in early research
- Governance sandboxes - critically, the bill does not make the mistake of trying to fix everything at once. Its mandate is to support sandboxes, innovative trial models
With this, the US has a real shot at retaining its competitive advantage in biotech, and could do right by millions of patients to access trials in the US instead of abroad.View quoted post on X
Can data from health records and insurance claims make medical research faster, cheaper, and more informative?
Join us Monday, Nov 9 at 10:30 AM ET for a live expert panel on real-world evidence in clinical research and regulatory decision-making.
Join us Monday, Nov 9 at 10:30 AM ET for a live expert panel on real-world evidence in clinical research and regulatory decision-making.